680 related articles for article (PubMed ID: 22721635)
41. Intravaginal administration of gelatine capsules containing freeze-dried autochthonous lactobacilli: a double-blind, randomised clinical trial of safety.
De Gregorio PR; Maldonado NC; Pingitore EV; Terraf MCL; Tomás MSJ; de Ruiz CS; Santos V; Wiese B; Bru E; Paiz MC; Reina MF; Schujman DE; Nader-Macías MEF
Benef Microbes; 2020 Feb; 11(1):5-17. PubMed ID: 32066254
[TBL] [Abstract][Full Text] [Related]
42. [Effectiveness of oral administration of Lactobacillus paracasei subsp. paracasei F19 in association with vaginal suppositories of Lactobacillus acidofilus in the treatment of vaginosis and in the prevention of recurrent vaginitis].
Delia A; Morgante G; Rago G; Musacchio MC; Petraglia F; De Leo V
Minerva Ginecol; 2006 Jun; 58(3):227-31. PubMed ID: 16783294
[TBL] [Abstract][Full Text] [Related]
43. Effectiveness of vaginal tablets containing lactobacilli versus pH tablets on vaginal health and inflammatory cytokines: a randomized, double-blind study.
Hemalatha R; Mastromarino P; Ramalaxmi BA; Balakrishna NV; Sesikeran B
Eur J Clin Microbiol Infect Dis; 2012 Nov; 31(11):3097-105. PubMed ID: 22777592
[TBL] [Abstract][Full Text] [Related]
44. Restoring vaginal microbiota: biological control of bacterial vaginosis. A prospective case-control study using Lactobacillus rhamnosus BMX 54 as adjuvant treatment against bacterial vaginosis.
Recine N; Palma E; Domenici L; Giorgini M; Imperiale L; Sassu C; Musella A; Marchetti C; Muzii L; Benedetti Panici P
Arch Gynecol Obstet; 2016 Jan; 293(1):101-107. PubMed ID: 26142892
[TBL] [Abstract][Full Text] [Related]
45. Characterization of vaginal lactobacilli in women after kidney transplantation.
Martirosian G; Radosz-Komoniewska H; Pietrzak B; Ekiel A; Kamiński P; Aptekorz M; Doleżych H; Samulska E; Jóźwiak J
Anaerobe; 2012 Apr; 18(2):209-13. PubMed ID: 22240292
[TBL] [Abstract][Full Text] [Related]
46. Effect of lactobacilli administration in the vaginal tract of mice: evaluation of side effects and local immune response by local administration of selected strains.
Vintiñi E; Ocaña V; Elena Nader-Macías M
Methods Mol Biol; 2004; 268():401-10. PubMed ID: 15156050
[TBL] [Abstract][Full Text] [Related]
47. Supplementation of standard antibiotic therapy with oral probiotics for bacterial vaginosis and aerobic vaginitis: a randomised, double-blind, placebo-controlled trial.
Heczko PB; Tomusiak A; Adamski P; Jakimiuk AJ; Stefański G; Mikołajczyk-Cichońska A; Suda-Szczurek M; Strus M
BMC Womens Health; 2015 Dec; 15():115. PubMed ID: 26635090
[TBL] [Abstract][Full Text] [Related]
48. Vaginal retention of locally administered clindamycin.
Eriksson K; Larsson PG; Nilsson M; Forsum U
APMIS; 2011 Jun; 119(6):373-6. PubMed ID: 21569095
[TBL] [Abstract][Full Text] [Related]
49. [Probiotic monotherapy of bacterial vaginosis: a open, randomized trial].
Kovachev S; Dobrevski-Vacheva R
Akush Ginekol (Sofiia); 2013; 52 Suppl 1():36-42. PubMed ID: 24294744
[TBL] [Abstract][Full Text] [Related]
50. Therapy of bacterial vaginosis using exogenously-applied Lactobacilli acidophili and a low dose of estriol: a placebo-controlled multicentric clinical trial.
Parent D; Bossens M; Bayot D; Kirkpatrick C; Graf F; Wilkinson FE; Kaiser RR
Arzneimittelforschung; 1996 Jan; 46(1):68-73. PubMed ID: 8821521
[TBL] [Abstract][Full Text] [Related]
51. Probiotics for the treatment of women with bacterial vaginosis.
Falagas M; Betsi GI; Athanasiou S
Clin Microbiol Infect; 2007 Jul; 13(7):657-64. PubMed ID: 17633390
[TBL] [Abstract][Full Text] [Related]
52. A pilot study evaluating the safety of vaginal administration of a multi-particulate pellet formulation.
Santiago GL; Verstraelen H; Poelvoorde N; De Corte S; Claeys G; Trog M; De Backer E; Saerens B; Vervaet C; De Boeck F; Van Bortel L; Remon JP; Temmerman M; Vaneechoutte M; Verhelst R
Eur J Pharm Biopharm; 2009 Nov; 73(3):399-403. PubMed ID: 19733660
[TBL] [Abstract][Full Text] [Related]
53. The dynamics of vaginal and rectal Lactobacillus spp. flora in subsequent trimesters of pregnancy in healthy Polish women, assessed using the Sanger sequencing method.
Dobrut A; Gosiewski T; Pabian W; Bodaszewska-Lubas M; Ochonska D; Bulanda M; Brzychczy-Wloch M
BMC Pregnancy Childbirth; 2018 Aug; 18(1):350. PubMed ID: 30157784
[TBL] [Abstract][Full Text] [Related]
54. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
[TBL] [Abstract][Full Text] [Related]
55. Probiotics for prevention of recurrent vulvovaginal candidiasis: a review.
Falagas ME; Betsi GI; Athanasiou S
J Antimicrob Chemother; 2006 Aug; 58(2):266-72. PubMed ID: 16790461
[TBL] [Abstract][Full Text] [Related]
56. The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species.
Antonio MA; Hawes SE; Hillier SL
J Infect Dis; 1999 Dec; 180(6):1950-6. PubMed ID: 10558952
[TBL] [Abstract][Full Text] [Related]
57. Activity of a Lactobacillus acidophilus-based douche for the treatment of bacterial vaginosis.
Drago L; De Vecchi E; Nicola L; Zucchetti E; Gismondo MR; Vicariotto F
J Altern Complement Med; 2007 May; 13(4):435-8. PubMed ID: 17532736
[TBL] [Abstract][Full Text] [Related]
58. New evidence on oral L. plantarum P17630 product in women with history of recurrent vulvovaginal candidiasis (RVVC): a randomized double-blind placebo-controlled study.
Vladareanu R; Mihu D; Mitran M; Mehedintu C; Boiangiu A; Manolache M; Vladareanu S
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):262-267. PubMed ID: 29364495
[TBL] [Abstract][Full Text] [Related]
59. Impact of oral administration of four
de Vrese M; Laue C; Papazova E; Petricevic L; Schrezenmeir J
Benef Microbes; 2019 May; 10(5):483-496. PubMed ID: 31012733
[TBL] [Abstract][Full Text] [Related]
60. Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis.
Anukam KC; Osazuwa E; Osemene GI; Ehigiagbe F; Bruce AW; Reid G
Microbes Infect; 2006 Oct; 8(12-13):2772-6. PubMed ID: 17045832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
